A dose-response meta-analysis of green tea consumption and breast cancer risk

References

• Berlin JA, Longnecker MP, Greenland S. 1993. Meta-analysis of epidemiologic dose-response data. Epidemiology. 4(3):218–228.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Cabrera C, Artacho R, Gimenez R. 2006. Beneficial effects of green tea–a review. J Am Coll Nutr. 25(2):79–99.
   PubMed Web of Science ®Google Scholar
• Carter O, Dashwood RH, Wang R, Dashwood WM, Orner GA, Fischer KA, Lohr CV, Pereira CB, Bailey GS, Williams DE. 2007. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr Cancer. 58(1):60–65.
   PubMed Web of Science ®Google Scholar
• Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, et al. 2008. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 9(8):730–756.
   PubMed Web of Science ®Google Scholar
• Crous-Maso J, Palomeras S, Relat J, Camó C, Martínez-Garza Ú, Planas M, Feliu L, Puig M T. 2018. (-) Epigallocatechin 3-gallate synthetic analogues inhibit fatty acid synthase and show anticancer activity in triple negative breast cancer. Molecules. 23:1160.
   Web of Science ®Google Scholar
• Dai Q, Shu XO, Li H, Yang G, Shrubsole MJ, Cai H, Ji B, Wen W, Franke A, Gao YT, et al. 2010. Is green tea drinking associated with a later onset of breast cancer?. Ann Epidemiol. 20(1):74–81.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Bray F, Pineros M, Znaor A. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144:1941–1953.
   PubMed Web of Science ®Google Scholar
• Gan RY, Li HB, Sui ZQ, Corke H. 2018. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Crit Rev Food Sci Nutr. 58(6):924–941.
   PubMed Web of Science ®Google Scholar
• Gianfredi V, Nucci D, Abalsamo A, Acito M, Villarini M, Moretti M, Realdon S. 2018. Green tea consumption and risk of breast cancer and recurrence – a systematic review and meta-analysis of observational studies. Nutrients. 10(12):1886.
   Web of Science ®Google Scholar
• Gianfredi V, Nucci D, Vannini S, Villarini M, Moretti M. 2017. In vitro biological effects of sulforaphane (SFN), epigallocatechin-3-gallate (EGCG), and curcumin on breast cancer cells: a systematic review of the literature. Nutr Cancer. 69:969–978.
   PubMed Web of Science ®Google Scholar
• Greenland S. 1995. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 6(4):356–365.
   PubMed Web of Science ®Google Scholar
• Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S, Talbot W. 2003. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr. 133(10):3303s–3309s.
   PubMed Web of Science ®Google Scholar
• Higdon JV, Frei B. 2003. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 43(1):89–143.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, Yu MC. 2008. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis. 29(10):1967–1972.
   PubMed Web of Science ®Google Scholar
• Inoue M, Sasazuki S, Wakai K, Suzuki T, Matsuo K, Shimazu T, Tsuji I, Tanaka K, Mizoue T, Nagata C, et al. 2009. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut. 58(10):1323–1332.
   PubMed Web of Science ®Google Scholar
• Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N, Tominaga S. 2001. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 167:175–182.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, Willett WC, Tsugane S. 2010. Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res. 12(5):R88.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Mizusawa J, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Tsugane S. 2014. Green tea consumption and breast cancer risk in Japanese women: a case-control study. Nutr Cancer. 66(1):57–67.
   PubMed Web of Science ®Google Scholar
• Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, Yang GY, Liu YY, Hou Z, Lin Y, et al. 2005. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65(22):10623–10631.
   PubMed Web of Science ®Google Scholar
• Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, Mabuchi K. 1999. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 81(7):1248–1256.
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Hara Y. 1999. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res. 436(1):69–97.
   PubMed Web of Science ®Google Scholar
• Li M, Tse LA, Chan WC, Kwok CH, Leung SL, Wu C, Yu WC, Yu IT, Yu CH, Wang F, et al. 2016. Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong. Cancer Epidemiol. 40:73–78.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu S, Zhou H, Hanson T, Yang L, Chen Z, Zhou M. 2016. Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men. Eur J Epidemiol. 31(9):853–865.
   PubMed Web of Science ®Google Scholar
• Makiuchi T, Sobue T, Kitamura T, Ishihara J, Sawada N, Iwasaki M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S. 2016. Association between green tea/coffee consumption and biliary tract cancer: a population-based cohort study in Japan. Cancer Sci. 107(1):76–83.
   PubMed Web of Science ®Google Scholar
• Mena S, Ortega A, Estrela JM. 2009. Oxidative stress in environmental-induced carcinogenesis. Mutat Res. 674(1–2):36–44.
   PubMed Web of Science ®Google Scholar
• Mizoo T, Taira N, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, et al. 2013. Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women. BMC Cancer. 13(1):565.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Nagano J, Kono S, Preston DL, Mabuchi K. 2001. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control. 12(6):501–508.
   PubMed Web of Science ®Google Scholar
• Najaf Najafi M, Salehi M, Ghazanfarpour M, Hoseini ZS, Khadem-Rezaiyan M. 2018. The association between green tea consumption and breast cancer risk: a systematic review and meta-analysis. Phytother Res. 32:1855–1864.
   PubMed Web of Science ®Google Scholar
• Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. 1998. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 89(3):254–261.
   PubMedGoogle Scholar
• Ogunleye AA, Xue F, Michels KB. 2010. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat. 119(2):477–484.
   PubMed Web of Science ®Google Scholar
• Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, Cai Q, Gu K, Ruan ZX, Gao YT, et al. 2009. Drinking green tea modestly reduces breast cancer risk. J Nutr. 139(2):310–316.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Sun CL, Yuan JM, Koh WP, Yu MC. 2006. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 27(7):1310–1315.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Tsubono Y, Nakaya N, Suzuki Y, Koizumi Y, Tsuji I. 2004. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer. 90(7):1361–1363.
   PubMed Web of Science ®Google Scholar
• Tang N, Wu Y, Zhou B, Wang B, Yu R. 2009. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 65(3):274–283.
   PubMed Web of Science ®Google Scholar
• Wang L, Liao WC, Tsai CJ, Wang LR, Mao IF, Chen CC, Kao PF, Yao CC. 2013. The effects of perceived stress and life style leading to breast cancer. Women Health. 53(1):20–40.
   PubMed Web of Science ®Google Scholar
• Wei R, Mao L, Xu P, Zheng X, Hackman RM, Mackenzie GG, Wang Y. 2018. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models. Food Funct. 9(11):5682–5696.
   PubMed Web of Science ®Google Scholar
• Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC. 2003. Green tea and risk of breast cancer in Asian Americans. Int J Cancer. 106(4):574–579.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang D, Kang S. 2013. Black tea, green tea and risk of breast cancer: an update. Springerplus. 2(1):240
   PubMedGoogle Scholar
• Yang CS, Wang X, Lu G, Picinich SC. 2009. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 9(6):429–439.
   PubMed Web of Science ®Google Scholar
• Yang G, Zheng W, Xiang YB, Gao J, Li HL, Zhang X, Gao YT, Shu XO. 2011. Green tea consumption and colorectal cancer risk: a report from the Shanghai Men’s Health Study. Carcinogenesis. 32(11):1684–1688.
   PubMed Web of Science ®Google Scholar
• Yuan JM, Koh WP, Sun CL, Lee HP, Yu MC. 2005. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis. 26(8):1389–1394.
   PubMed Web of Science ®Google Scholar
• Zhang M, Holman CD, Huang JP, Xie X. 2007. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis. 28(5):1074–1078.
   PubMed Web of Science ®Google Scholar